Abstract
Pulmonary growths produced by intravenous injection of methycholanthrene-induced sarcoma cells were controlled or suppressed by specific immunostimulation with BCG-sarcoma cell inocula at subcutaneous sites or by intravenous treatment with BCG alone. The response was dependent upon the immunogenicity of the treated tumour so that in comparison, intravenous injection of BCG enhanced rather than suppressed pulmonary growths of transferred cells of several weakly immunogenic tumours including a spontaneously arising sarcoma and an epithelioma as well as a carcinogen-induced mammary carcinoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Baldwin, R., Pimm, M. BCG Immunotherapy of Pulmonary Growths from Intravenously Transferred Rat Tumour Cells. Br J Cancer 27, 48–54 (1973). https://doi.org/10.1038/bjc.1973.6
Issue Date:
DOI: https://doi.org/10.1038/bjc.1973.6
This article is cited by
-
Histopathology of BCG and thiotepa treated bladders
Urological Research (1986)
-
Experimental percutaneous renal embolization using BCG-saturated gelfoam
Cardiovascular and Interventional Radiology (1982)
-
Antigenic heterogeneity of the guinea pig line 10 hepatocarcinoma. Implications for active specific immunotherapy
Cancer Immunology, Immunotherapy (1982)
-
The negative systemic effect of BCGcw inoculated intraperitoneally
Cancer Immunology, Immunotherapy (1981)
